Antigen-binding molecule comprising altered antibody variable region binding CD3 and CD137 Grant US-11952422-B2 United States of America 09 Apr 2024
Bispecific antigen-binding molecules and methods of use Grant US-11866498-B2 United States of America 09 Jan 2024
Bispecific antibodies against CD3 and CD20 for treating chronic lymphocytic leukemia Grant US-11858995-B2 United States of America 02 Jan 2024
Bispecific antibody against CD3 and CD20 in combination therapy for treating diffuse… Grant US-11845805-B2 United States of America 19 Dec 2023
Antigen-binding molecule containing modified antibody variable region Grant US-11739149-B2 United States of America 29 Aug 2023
CD137- and DLL3-targeting multispecific antigen-binding molecules Grant US-11718672-B2 United States of America 08 Aug 2023
CD30 bispecific antibodies and method of immunotherapy of CD30+ malignancies Grant US-11667721-B2 United States of America 06 Jun 2023
Bispecific chimeric antigen receptors, encoding polynucleotides thereof and methods of… Grant US-11639387-B2 United States of America 02 May 2023
Anti-CD3 antibody and molecules comprising the antibody Grant US-11618785-B2 United States of America 04 Apr 2023
Bispecific antibody against CD3 and CD20 in combination therapy for treating follicular… Grant US-11608383-B2 United States of America 21 Mar 2023
Anti-CD30 antibodies and methods for treating CD30+ cancer Grant US-11584799-B2 United States of America 21 Feb 2023
Bispecific antibody against CD3 and CD20 in combination therapy for treating diffuse… Grant US-11548952-B2 United States of America 10 Jan 2023
Bispecific antibody against CD3 and CD20 in combination therapy for treating follicular… Grant US-11535679-B2 United States of America 27 Dec 2022
Dosing for treatment with anti-CD20/anti-CD3 bispecific antibodies Grant US-11466094-B2 United States of America 11 Oct 2022
CD3-targeting and DLL3-targeting multispecific antigen-binding molecules and uses thereof Grant US-11274151-B2 United States of America 15 Mar 2022
Humanized and affinity matured antibodies to FcRH5 and methods of use Grant US-11192950-B2 United States of America 07 Dec 2021
Library of antigen-binding molecules including modified antibody variable region Grant US-11154615-B2 United States of America 26 Oct 2021
Drug-conjugated bi-specific antigen-binding constructs Grant US-11147886-B2 United States of America 19 Oct 2021
Antigen-binding molecule containing modified Fc region Grant US-11142563-B2 United States of America 12 Oct 2021
Polynucleotides encoding bispecific chimeric antigen receptors Grant US-10829556-B2 United States of America 10 Nov 2020
MULTISPECIFIC ANTIBODIES AND USE THEREOF Application WO-2019202041-A1 World Intellectual Property Organisation (WIPO) 24 Oct 2019
Humanized and affinity matured antibodies to FcRH5 and methods of use Grant US-10323094-B2 United States of America 18 Jun 2019
ANTI-CD3 ANTIBODIES AND METHODS OF USE Application WO-2016204966-A1 World Intellectual Property Organisation (WIPO) 22 Dec 2016
ANTI-TIM-3 ANTIBODIES Application WO-2016068803-A1 World Intellectual Property Organisation (WIPO) 06 May 2016
ANTI-TIM-3 ANTIBODIES Application WO-2016068802-A1 World Intellectual Property Organisation (WIPO) 06 May 2016
BISPECIFIC HER2 AND CD3 BINDING MOLECULES Application WO-2016014942-A1 World Intellectual Property Organisation (WIPO) 28 Jan 2016